Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Simon Fraser University

$25,000.00

Ultra-sensitive graphene-based immunoelectrochemical sensor for the quantitation of cardiacTroponin I

EF 2016-17

Résumé
This NSERC ENGAGE proposal initiates a short-term collaborative project between Dr. Yu's research team atSimon Fraser University (SFU) and a local biotechnology company, Vancouver Biotech Ltd. (VBL) to developa portable, ultra-sensitive graphene-based immunoelectrochemical sensor for the quantitation of cardiacTroponin I (cTnI). Particularly, cTnI is a clinically validated, early stage cardiac marker for acute myocardialinfarction (AMI), a predominate disease that leads to more than one-tenths of deaths in Canada and worldwide.The existing methods for cTnI detection, such as lateral flow immunochromatographic assay andenzyme-linked immunosorbent assay (ELISA) are either not quantitative or time consuming.The research will focus on the establishment of a novel sensor platform by employing graphene-basedmacroelectrodes, for which comprehensive electrochemical tests will be performed first. The comparativestudies with VBL's ELISA assay kits will be carried out subsequently. Beyond the validation of theelectrochemical detection principle, this new collaboration will promote the proof-of-concept research to theprototype stage of pre-commercialization. The developed cTnI sensors based on the advancedimmunoelectrochemistry and nanotechnology will have the advantages of faster detection and higher sensitivityin comparison with the ELISA assay kits currently marketed by VBL.Successful completion of this project will serve as a ""seed"" for the long-term collaboration between SFU andVancouver Biotech Ltd. on developing electrochemical sensing technology for various analytes that areimportant for medicine, environment, and food safety. The execution of the project also provides a uniquetraining platform for graduate students and research associates in an interdisciplinary field of nanomaterials,analytical chemistry, and biosensing technology.
Programme
Engage Grants Program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
507431-2016
Name nom
Yu, Hogan
Department département
Chemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
1
Application title
Ultra-sensitive graphene-based immunoelectrochemical sensor for the quantitation of cardiacTroponin I
Keyword
NSERC
Application summary
This NSERC ENGAGE proposal initiates a short-term collaborative project between Dr. Yu's research team atSimon Fraser University (SFU) and a local biotechnology company, Vancouver Biotech Ltd. (VBL) to developa portable, ultra-sensitive graphene-based immunoelectrochemical sensor for the quantitation of cardiacTroponin I (cTnI). Particularly, cTnI is a clinically validated, early stage cardiac marker for acute myocardialinfarction (AMI), a predominate disease that leads to more than one-tenths of deaths in Canada and worldwide.The existing methods for cTnI detection, such as lateral flow immunochromatographic assay andenzyme-linked immunosorbent assay (ELISA) are either not quantitative or time consuming.The research will focus on the establishment of a novel sensor platform by employing graphene-basedmacroelectrodes, for which comprehensive electrochemical tests will be performed first. The comparativestudies with VBL's ELISA assay kits will be carried out subsequently. Beyond the validation of theelectrochemical detection principle, this new collaboration will promote the proof-of-concept research to theprototype stage of pre-commercialization. The developed cTnI sensors based on the advancedimmunoelectrochemistry and nanotechnology will have the advantages of faster detection and higher sensitivityin comparison with the ELISA assay kits currently marketed by VBL.Successful completion of this project will serve as a ""seed"" for the long-term collaboration between SFU andVancouver Biotech Ltd. on developing electrochemical sensing technology for various analytes that areimportant for medicine, environment, and food safety. The execution of the project also provides a uniquetraining platform for graduate students and research associates in an interdisciplinary field of nanomaterials,analytical chemistry, and biosensing technology.